JMP reiterates Market Outperform rating on LeMaitre Vascular stock ahead of earnings

Investing.com - JMP Securities has reiterated its Market Outperform rating and $113.00 price target on LeMaitre Vascular (NASDAQ:LMAT) ahead of the company’s second-quarter 2025 earnings release scheduled for August 5. The target represents significant upside from the current price of $82.43, though InvestingPro analysis suggests the stock is currently trading above its Fair Value.

The firm maintains its positive outlook following LeMaitre’s first-quarter guidance update, which raised full-year 2025 revenue growth projections by 300 basis points to 13% year-over-year organic growth.

JMP notes that while LeMaitre adjusted its operating margin and EPS guidance slightly downward in the first quarter, these changes primarily reflect the company’s accelerated expansion of its sales force, which grew by 12 representatives to 164 from 152.

The research firm views these guidance adjustments as timing-related factors, suggesting potential upside to both top and bottom-line results as the newly added sales representatives improve utilization throughout the year.

JMP also highlights LeMaitre’s early success with list price increases, which contributed 9% to total sales in the first quarter of 2025, reinforcing confidence in the company’s ability to drive sales growth and operating leverage through 2025 and 2026.

In other recent news, LeMaitre Vascular Inc . reported its first-quarter 2025 earnings, showcasing a 13% organic sales growth, which brought in $58.8 million. The company’s revenue exceeded expectations, reaching $59.9 million compared to the anticipated $58.13 million. However, the earnings per share (EPS) of $0.48 did not meet the projected $0.51. In addition to financial results, LeMaitre Vascular held its annual stockholder meeting where key decisions were made. Shareholders elected three Class I directors for three-year terms, including George W. LeMaitre, David B. Roberts, and Martha Shadan. The meeting also involved the ratification of the company’s accounting firm. These developments reflect the company’s ongoing activities and financial performance.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.